Sergey Kulemzin
Sergey Kulemzin
Researcher, Institute of Molecular and Cellular Biology SB RAS
Подтвержден адрес электронной почты в домене mcb.nsc.ru
Название
Процитировано
Процитировано
Год
Evasion of the innate immune response: the Old World alphavirus nsP2 protein induces rapid degradation of Rpb1, a catalytic subunit of RNA polymerase II
I Akhrymuk, SV Kulemzin, EI Frolova
Journal of virology 86 (13), 7180-7191, 2012
1752012
FCRLA is a resident endoplasmic reticulum protein that associates with intracellular Igs, IgM, IgG and IgA
T Santiago, SV Kulemzin, ES Reshetnikova, NA Chikaev, OY Volkova, ...
International immunology 23 (1), 43-53, 2011
312011
VEGFR2-specific FnCAR effectively redirects the cytotoxic activity of T cells and YT NK cells
SV Kulemzin, AA Gorchakov, AN Chikaev, VV Kuznetsova, OY Volkova, ...
Oncotarget 9 (10), 9021, 2018
152018
FCRL6 receptor: Expression and associated proteins
SV Kulemzin, AY Zamoshnikova, MY Yurchenko, NY Vitak, AM Najakshin, ...
Immunology letters 134 (2), 174-182, 2011
152011
Challenges and prospects of chimeric antigen receptor T-cell therapy for metastatic prostate cancer
AA Gorchakov, SV Kulemzin, GV Kochneva, AV Taranin
European urology 77 (3), 299-308, 2020
122020
Engineering Chimeric Antigen Receptors
SV Kulemzin, VV Kuznetsova, M Mamonkin, AV Taranin
Acta Naturae (англоязычная версия) 9 (1 (32)), 2017
122017
Design and analysis of stably integrated reporters for inducible transgene expression in human T cells and CAR NK-cell lines
SV Kulemzin, DA Matvienko, AH Sabirov, AM Sokratyan, DS Chernikova, ...
BMC medical genomics 12 (2), 44, 2019
82019
CAR T-cell therapy: Balance of efficacy and safety
SV Kulemzin, VV Kuznetsova, M Mamonkin, AV Taranin, AA Gorchakov
Molecular Biology 51 (2), 237-250, 2017
82017
COVID-19. Aetiology, pathogenesis, diagnosis and treatment
VP Baklaushev, SV Kulemzin, АА Gorchakov, VN Lesnyak, ...
Journal of Clinical Practice 11 (1), 7-20, 2020
72020
Development and Characterization of Domain-Specific Monoclonal Antibodies Produced Against Human SLAMF9
O Volkova, S Guselnikov, L Mechetina, N Chikaev, K Baranov, ...
Monoclonal antibodies in immunodiagnosis and immunotherapy 33 (4), 209-214, 2014
52014
Analysis of in vitro activity of PSCA-specific CARs in the context of human NK cell line YT
DA Matvienko, SV Kulemzin, AS Smagina, TN Belovezhets, AN Chikaev, ...
Cell Ther. Transplant. 7, 70-76, 2018
42018
Characterization of human FCRLA isoforms
S Kulemzin, N Chikaev, O Volkova, E Reshetnikova, A Taranin, ...
Immunology letters 152 (2), 153-158, 2013
42013
Modular lentiviral vector system for chimeric antigen receptor design optimization
SV Kulemzin, NA Chikaev, OY Volkova, VV Kuznetsova, AV Taranin, ...
Russian Journal of Bioorganic Chemistry 43 (2), 107-114, 2017
32017
Combination of Oncolytic Virotherapy and CAR T/NK Cell Therapy for the Treatment of Cancer
GV Kochneva, GF Sivolobova, AV Tkacheva, AA Gorchakov, SV Kulemzin
Molecular Biology 54 (1), 1-12, 2020
22020
ECAR-NK Cell Platform: Enhancing the CAR-Mediated NK Cell Cytotoxicity via Blockade of the CD47/SIRPa Axis
A Gorchakov, AN Chikaev, SV Kulemzin, OY Volkova, DS Chernikova, ...
MOLECULAR THERAPY 26 (5), 199-199, 2018
12018
Diversity of immunoglobulin light chain genes in non-teleost ray-finned fish uncovers IgL subdivision into five ancient isotypes
SV Guselnikov, KO Baranov, AM Najakshin, LV Mechetina, NA Chikaev, ...
Frontiers in Immunology 9, 2018
12018
Comparative analysis of lactaptin activity when produced in bacterial or eukaryotic expression systems
OA Koval, OY Volkova, AA Gorchakov, SV Kulemzin, AV Tkachenko, ...
Vavilovskii Zhurnal Genetiki i Selektsii 21 (7), 764-769, 2017
12017
IDENTIFICATION OF THE HUMAN SLAMF9-RECEPTOR COMPLEX: P145
A Sokratian, K Baranov, S Guselnikov, N Chikaev, O Volkova, ...
Tissue Antigens 85 (5), 381-382, 2015
12015
FCRLA is an intracellular FcR-related protein that binds IgM, IgG and IgA isotypes in B cells (45.11)
P Burrows, T Santiago, S Kulemzin, E Reshetnikova, N Chikaev, ...
The Journal of Immunology 186 (1 Supplement), 45.11-45.11, 2011
12011
VAV1‐overexpressing YT cells display improved cytotoxicity against malignant cells
AS Smagina, SV Kulemzin, GM Yusubalieva, AG Kedrova, AE Sanzharov, ...
Biotechnology and Applied Biochemistry, 2020
2020
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20